124 related articles for article (PubMed ID: 19074644)
1. Posttranslational regulation of Abcc2 expression by SUMOylation system.
Minami S; Ito K; Honma M; Ikebuchi Y; Anzai N; Kanai Y; Nishida T; Tsukita S; Sekine S; Horie T; Suzuki H
Am J Physiol Gastrointest Liver Physiol; 2009 Feb; 296(2):G406-13. PubMed ID: 19074644
[TBL] [Abstract][Full Text] [Related]
2. Ubc9 fusion-directed SUMOylation (UFDS): a method to analyze function of protein SUMOylation.
Jakobs A; Koehnke J; Himstedt F; Funk M; Korn B; Gaestel M; Niedenthal R
Nat Methods; 2007 Mar; 4(3):245-50. PubMed ID: 17277783
[TBL] [Abstract][Full Text] [Related]
3. Enhanced detection of in vivo SUMO conjugation by Ubc9 fusion-dependent sumoylation (UFDS).
Niedenthal R
Methods Mol Biol; 2009; 497():63-79. PubMed ID: 19107411
[TBL] [Abstract][Full Text] [Related]
4. Dnmt3b, de novo DNA methyltransferase, interacts with SUMO-1 and Ubc9 through its N-terminal region and is subject to modification by SUMO-1.
Kang ES; Park CW; Chung JH
Biochem Biophys Res Commun; 2001 Dec; 289(4):862-8. PubMed ID: 11735126
[TBL] [Abstract][Full Text] [Related]
5. The UBC9 E2 SUMO conjugating enzyme binds the PR-Set7 histone methyltransferase to facilitate target gene repression.
Spektor TM; Congdon LM; Veerappan CS; Rice JC
PLoS One; 2011; 6(7):e22785. PubMed ID: 21829513
[TBL] [Abstract][Full Text] [Related]
6. Interaction of hepatocyte nuclear factors in transcriptional regulation of tissue specific hormonal expression of human multidrug resistance-associated protein 2 (abcc2).
Qadri I; Hu LJ; Iwahashi M; Al-Zuabi S; Quattrochi LC; Simon FR
Toxicol Appl Pharmacol; 2009 Feb; 234(3):281-92. PubMed ID: 19010343
[TBL] [Abstract][Full Text] [Related]
7. Repression of Smad4 transcriptional activity by SUMO modification.
Long J; Wang G; He D; Liu F
Biochem J; 2004 Apr; 379(Pt 1):23-9. PubMed ID: 14750902
[TBL] [Abstract][Full Text] [Related]
8. In vitro modification of human centromere protein CENP-C fragments by small ubiquitin-like modifier (SUMO) protein: definitive identification of the modification sites by tandem mass spectrometry analysis of the isopeptides.
Chung TL; Hsiao HH; Yeh YY; Shia HL; Chen YL; Liang PH; Wang AH; Khoo KH; Shoei-Lung Li S
J Biol Chem; 2004 Sep; 279(38):39653-62. PubMed ID: 15272016
[TBL] [Abstract][Full Text] [Related]
9. Sumoylation of internally initiated Sp3 isoforms regulates transcriptional repression via a Trichostatin A-insensitive mechanism.
Spengler ML; Kennett SB; Moorefield KS; Simmons SO; Brattain MG; Horowitz JM
Cell Signal; 2005 Feb; 17(2):153-66. PubMed ID: 15494207
[TBL] [Abstract][Full Text] [Related]
10. ATP-binding cassette transporter isoform C2 localizes to the apical plasma membrane via interactions with scaffolding protein.
Emi Y; Nomura S; Yokota H; Sakaguchi M
J Biochem; 2011 Feb; 149(2):177-89. PubMed ID: 21059598
[TBL] [Abstract][Full Text] [Related]
11. Ubc9-mediated sumoylation leads to transcriptional repression of IRF-1.
Kim EJ; Park JS; Um SJ
Biochem Biophys Res Commun; 2008 Dec; 377(3):952-6. PubMed ID: 18955028
[TBL] [Abstract][Full Text] [Related]
12. Pias1 interaction and sumoylation of metabotropic glutamate receptor 8.
Tang Z; El Far O; Betz H; Scheschonka A
J Biol Chem; 2005 Nov; 280(46):38153-9. PubMed ID: 16144832
[TBL] [Abstract][Full Text] [Related]
13. Is Transthyretin a Regulator of Ubc9 SUMOylation?
Wieczorek E; Kędracka-Krok S; Sołtys K; Jankowska U; Hołubowicz R; Seliga J; Ożyhar A
PLoS One; 2016; 11(8):e0160536. PubMed ID: 27501389
[TBL] [Abstract][Full Text] [Related]
14. SUMOylation of Argonaute-2 regulates RNA interference activity.
Josa-Prado F; Henley JM; Wilkinson KA
Biochem Biophys Res Commun; 2015 Sep; 464(4):1066-1071. PubMed ID: 26188511
[TBL] [Abstract][Full Text] [Related]
15. Ubc9 promotes the stability of Smad4 and the nuclear accumulation of Smad1 in osteoblast-like Saos-2 cells.
Shimada K; Suzuki N; Ono Y; Tanaka K; Maeno M; Ito K
Bone; 2008 May; 42(5):886-93. PubMed ID: 18321803
[TBL] [Abstract][Full Text] [Related]
16. Role of an N-terminal site of Ubc9 in SUMO-1, -2, and -3 binding and conjugation.
Tatham MH; Kim S; Yu B; Jaffray E; Song J; Zheng J; Rodriguez MS; Hay RT; Chen Y
Biochemistry; 2003 Aug; 42(33):9959-69. PubMed ID: 12924945
[TBL] [Abstract][Full Text] [Related]
17. Ezrin regulates the expression of Mrp2/Abcc2 and Mdr1/Abcb1 along the rat small intestinal tract.
Nakano T; Sekine S; Ito K; Horie T
Am J Physiol Gastrointest Liver Physiol; 2013 Dec; 305(11):G807-17. PubMed ID: 24091598
[TBL] [Abstract][Full Text] [Related]
18. Ubc9 acetylation modulates distinct SUMO target modification and hypoxia response.
Hsieh YL; Kuo HY; Chang CC; Naik MT; Liao PH; Ho CC; Huang TC; Jeng JC; Hsu PH; Tsai MD; Huang TH; Shih HM
EMBO J; 2013 Mar; 32(6):791-804. PubMed ID: 23395904
[TBL] [Abstract][Full Text] [Related]
19. Transport-metabolism interplay: LXRalpha-mediated induction of human ABC transporter ABCC2 (cMOAT/MRP2) in HepG2 cells.
Adachi T; Nakagawa H; Hagiya Y; Yasuoka T; Ishikawa T
Mol Pharm; 2009; 6(6):1678-88. PubMed ID: 19588995
[TBL] [Abstract][Full Text] [Related]
20. Sumoylation and proteasomal activity determine the transactivation properties of the mineralocorticoid receptor.
Tirard M; Almeida OF; Hutzler P; Melchior F; Michaelidis TM
Mol Cell Endocrinol; 2007 Mar; 268(1-2):20-9. PubMed ID: 17314004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
